Mackay Sean (CIK 1875501) reported 11 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-23). Recent activity: Buy LAB (500,000 shares), Sell LAB (25,729 shares), Buy LAB (272,107 shares), Sell LAB (19,661 shares), Sell LAB (19,661 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-23 | STANDARD BIOTOOLS INC. (LAB) | SVP & Chief Business Officer | Buy | 500,000 | $0 |
| 2026-05-22 | STANDARD BIOTOOLS INC. (LAB) | SVP & Chief Business Officer | Sell | 25,729 | $25,729 |
| 2026-04-08 | STANDARD BIOTOOLS INC. (LAB) | SVP & Chief Business Officer | Buy | 272,107 | $0 |
| 2026-02-24 | STANDARD BIOTOOLS INC. (LAB) | SVP & Chief Business Officer | Sell | 19,661 | $22,610 |
| 2025-11-24 | STANDARD BIOTOOLS INC. (LAB) | SVP & Chief Business Officer | Sell | 19,661 | $25,166 |
| 2025-08-22 | STANDARD BIOTOOLS INC. (LAB) | SVP & Chief Business Officer | Sell | 19,661 | $24,969 |
| 2025-05-30 | STANDARD BIOTOOLS INC. (LAB) | SVP & Chief Business Officer | Sell | 23,919 | $26,072 |
| 2025-05-28 | STANDARD BIOTOOLS INC. (LAB) | SVP & Chief Business Officer | Sell | 13,217 | $12,424 |
| 2025-05-23 | STANDARD BIOTOOLS INC. (LAB) | SVP & Chief Business Officer | Sell | 12,838 | $13,223 |
| 2025-05-23 | STANDARD BIOTOOLS INC. (LAB) | SVP & Chief Business Officer | Sell | 12,536 | $12,536 |
| 2025-03-24 | STANDARD BIOTOOLS INC. (LAB) | SVP & Chief Business Officer | Buy | 281,667 | $0 |
Source: SEC Form 4 filings · as of 2026-06-23